Log in to save to my catalogue

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted...

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04760760v1

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Increased rates of sexually transmitted infections (STIs) are reported among men who have sex with men (MSM) and new interventions are needed. We aimed to assess whether post-exposure prophylaxis (PEP) with doxycycline could reduce the incidence of chlamydia or syphilis (or both) and whether the meningococcal group B vaccine (4CMenB) could reduce t...

Alternative Titles

Full title

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04760760v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04760760v1

Other Identifiers

ISSN

1473-3099,1474-4457

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(24)00236-6

How to access this item